Biocardia, Inc.
Clinical trials sponsored by Biocardia, Inc., explained in plain language.
-
Stem cells tested to heal COVID-Damaged lungs
Disease control TerminatedThis early-stage study aimed to test the safety of stem cell therapy for patients recovering from severe COVID-19 lung damage (ARDS). The treatment involved giving patients stem cells from donors to help reduce inflammation and promote healing. The study was withdrawn before any …
Phase: PHASE1 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Donor stem cells injected into failing hearts in new trial
Disease control OngoingThis study is testing whether stem cells from a donor's bone marrow can help improve heart function in people with chronic heart failure caused by a past heart attack. The cells are injected directly into the heart muscle using a special catheter. The main goals are to see if the…
Phase: PHASE1, PHASE2 • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Using your own cells to fight untreatable heart pain
Symptom relief OngoingThis trial is testing a new cell therapy for people with severe chest pain (angina) that doesn't respond to standard medications or procedures. Researchers are injecting a patient's own processed bone marrow cells directly into the heart muscle to see if it improves their ability…
Phase: NA • Sponsor: BioCardia, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC